Cardiovascular effects of Cassella 7657 and its interaction with adenosine, NAD and aminophylline in dogs.
D000241:Adenosine / Q000494:pharmacology*; D000628:Aminophylline / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D003374:Coumarins / Q000494:pharmacology*; D004285:Dogs; D004347:Drug Interactions; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D008738:Methyl Ethers / Q000494:pharmacology; D009025:Morpholines / Q000494:pharmacology*; D009206:Myocardium / Q000378:metabolism; D009243:NAD / Q000494:pharmacology*; D010100:Oxygen / Q000097:blood; D010101:Oxygen Consumption / Q000187:drug effects; D011651:Pulmonary Artery / Q000187:drug effects; D013997:Time Factors; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000494:pharmacology*
D003374:Coumarins; D008738:Methyl Ethers; D009025:Morpholines; D014665:Vasodilator Agents; D009243:NAD; D000628:Aminophylline; C006927:Cassella 7657; D000241:Adenosine; D010100:Oxygen